Endro Prasetyo Wahono
Department of Civil Engineering, Faculty of Engineering, Universitas Lampung, Bandar Lampung, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Determinants of Treatment Delay in Drug-Resistant Tuberculosis Patients Dyah Wulan Sumekar Rengganis Wardani; Fitria Saftarina; Endro Prasetyo Wahono
Bandung Conference Series: Medical Science 1547-1552
Publisher : UNISBA Press

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29313/bcsms.v5i3.21658

Abstract

Abstract. The incidence of drug-resistant (DR) tuberculosis (TB) is increasing worldwide. In Indonesia, DR-TB was 31,000 cases in 2024, also increasing compared to 28,000 cases in 2021. 78.2% of TB patients who were diagnosed with DR-TB experienced treatment delay of up to ten days. In addition, treatment delay in patients with DR-TB can increase risk of disease transmission, development of the disease into extensively DR-TB, and possibility of poor treatment outcomes. The aim of this study was to analyze determinants of treatment delay in DR-TB patients. This cross-sectional study was conducted at Abdoel Moeloek Regional General Hospital in Lampung Province, one of the referral hospitals for DR-TB in the province. The sample included all 20 DR-TB patients recorded in August 2025. Data was collected through interviews using a questionnaire, which then analyzed using chi-square test. The results showed no relationship between age, gender, education, occupation, income, comorbidities, distance, or cost to the hospital and treatment delay in DR-TB patients. However, the results revealed an association between loss to follow-up in previous treatments (p-value: 0.002; odds ratio [OR]: 8.182, 95% CI: 1.277–12.416), visiting to other health facilities after diagnosed as TB-RO (p-value: 0.027; OR: 8.182, 95% CI: 2,0 (1,67 – 2,38) and treatment delay in DR-TB patients. Loss to follow up in previous TB treatment related to low motivation of TB patients to take medical treatment. This not only encourages TB patients to fail in first-line treatment, but it also impacts treatment delay when they are DR-TB patients. Visiting other health facilities rather than DR-TB hospital directly will also prolong treatment delay. In conclusion, a strategy is needed to manage TB patients who are lost to follow-up and visiting other health services to avoid increasing the burden on DR-TB patients.